Paradigm Picks Newsletter 2021/Dec/02
Welcome Back!
It’s the most wonderful time of the year! Tax loss season! We hope you all set funds aside for the pullback that was November! We have continued to buy dips as they have presented themselves in our various holdings. We are looking forward to more deals this month and excited for January 2022!
We have been reaching out to the CEO’s of our various investments to stay up-to date on their respective progress and initiatives. As always, due to legal reasons, CEO’s may be “tight lipped” regarding various questions, however provide a general sentiment for their projects going forward.
For real-time updates and commentary, follow us on Twitter at:
Paradigm Market Research Inc. (@PMResearch_ca) / Twitter
Join the conversation on our New Discord channel!
Updates
Emerita Resources EMO : What an eventful November for the Spanish Princess! Between:
Anticipation of the recent PP coming free trading last month,
a news article out of spain dissemingating false information on the Aznalcollar tender,
False reports of work being conducted on the Aznalcollar property and,
EMO.V surging as high as $4.14,
we saw some significant downside pressure. Fortunately (and unsurprizingly) the news article suggesting Emerita had no right to the Aznalcollar tender was debunked.
Regarding the private placement coming free trading last month, we were greeted with some fantastic news regarding Eric Sprott. As stated In the November 15th 2021 News release,
“ Mr. Eric Sprott, ….., exercised a total of 6,818,181 Warrants at an exercise price of $0.30 per common share (“Share”).
Following the completion of the exercise of his Warrants, Mr. Sprott beneficially owns and controls 20,454,544 Shares, representing approximately 10.7% of the issued and outstanding Shares on a non-diluted basis. Prior to the Warrants exercise, Mr. Sprott beneficially owned and controlled 13,636,363 Shares and 6,818,181 Warrants, representing approximately 7.4% of the issued and outstanding Shares of the Company on a non-diluted basis, and 10.7% on a partially diluted basis.”
We were incredibly encouraged by Sprotts decision to “double down” on EMO.V being one of the most significant votes of confidence for the stock in recent memory.
Speaking of “votes of confidence,” once again we give a tip of the cap (pun intended) to “Doc Jones the Resource Investor” and management for the fruitful Due dilligence that came out of the recent site visit. Please see below regarding the insightful interviews Doc Jones provided:
Interview with EMO President Joaquin Merino
Interview with David Gower Re: Site tour
One of our biggest takeaways regarding the site tour information was the fact that Emerita plans on expanding the number of drills on IBW alone to EIGHT! In addition, feedback regarding the Aznalcollar property being put back in to production was very well received by the surrounding communities.
We thought we would add one additional note regarding future speculation. There is much excitement and interest regarding the Neuvo Tintillio property. While we agree with the addage a “bird in the hand…, we are further intruiged at the potential (positive) divergence between historical samples and future drill programs regarding Aznalcollar. Recent assays from IBW returned upwards of 60% higher grade compared to historical. Given the proximity of the two projects in conjunction with modern technology/mining methods, it is not out of the question to suggest that future mining at Aznalcollar could also yield higher grades than previously documented.
With this information, we have moved our (conservative) buyout price range to ~$25.00 CAD!
Bright Minds Biosciences DRUG : Bright minds Biosciences fell from recent highs since their listing on the NASDAQ. Naturally We have been adding and averaging down our position. Our confidence is further bolstered by the fact that CEO Ian Mcdonald had purchased over $100k CAD worth of shares in November 2021 as per SEDI! We believe any buys under $7.50 are of fantastic value with a longterm perspective.
As of November 30st 2021, Bright Minds Biosciences issued a news release regarding their Novel 5-HT2A Psychedelic Program
“Our 5-HT2A psychedelic drug discovery program is showing clear signs of success,” stated Dr. Alan Kozikowski, Ph.D., Chief Scientific Officer and Co-founder of Bright Minds. “To date, we have synthesized hundreds of de novo, novel compounds in our discovery program and are currently optimizing a select handful of the most encouraging molecules to take into late preclinical development. We are currently on track to announce our lead molecule in this program in the first quarter of 2022.”
As mentioned in previous issues, we believe Bright Mind’s biosciences along with the psychedelic’s market in general is still in its infancy. We have no issues adding sub $7.50, especially ~5.10!! We are certainly looking forward to gains from this stock in 2022.
Gold Mountain Mining Corp. GMTN : Gold Mountain has been busy! Since our last issue, they have been issued their permit from the ministry of mines, uplisted to the TSX and released assays including one of the widest recorded high grade intercepts at the Elk Property!
Drilling Highlights Include:
2.4m grading 20.2 g/t Au including 0.4m of 127.0 g/t Au
1.3m grading 6.87 g/t Au including 0.3m of 28.6 g/t Au
1.3m grading 4.48 g/t Au including 0.3m of 19.4 g/t Au
1.3m grading 4.25 g/t Au including 0.3m of 18.4 g/t Au
Given the recent retracement to $1.42 CAD, we see these levels as significant value as Gold Mountain agressively develops their project. Another company we belive will do well 2022!
KULR Technology Group inc. KULR : We hope you picked up a few more of these of these shares! KULR’s media team has been out in full force garnering coverage from multiple youtuber’s and news outlets. The coverage, in part has been due to KULR’s recent order from Lockheed Martin! See below:
KULR Technology Stock Is On A Run; Adds To 140% YTD Gains After - SOUTHEAST - NEWS CHANNEL NEBRASKA
As a result, the KULR share price has exploded to the upside from our original sub $2.00 USD buy recommendation to $3.47 USD at the time of writing. As the world continues to rely on clean and effecient energy/ storage management, you can bet KULR will continue to be at the forefront in 2022.
Insuraguest Technologies inc. ISGI: Tax loss season has not been friendly to Insuraguest Technologies - which is exactly why we are buying here! We believe that the market reaction to ISGI’s initial revenue was unfair and significantly oversold; this is an industry disrupting technology in the early stages of worldwide implementation. We are more interested in year over year revenue increases which we believe to be substantial. As mentioned in previous issues, when multi-billion dollar insurance agencies knock on your door, you know the returns will be significant down the road!
Speaking of which, as of December 2nd 2021, ISGI has announced an additional partnership with Suitelife! The share price at the time of writing has spiked has high as .24 CAD compared to brief lows of .18!
As always, seek professional financial advice and conduct your own due diligence prior to making any investment decisions,
Paradigm Market Research inc.
Consider supporting our free newsletter at: https://www.paradigmresearch.ca/our-team
Check out www.paradigmresearch.ca to view more of our content.
If you have any further questions about these companies, please do not hesitate to contact us. We are more than happy to assist you with real-time, up-to-date information.